|Articles|May 26, 2016
Challenges in 3D Bioprinting
Advertisement
Adam Feinberg, associate professor of Biomedical Engineering at Carnegie Mellon University, sat down with BioPharm International to discuss challenges in 3D bioprinting.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
3
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
4
Implementing Automation and Flexible Design for Allogeneic Manufacturing
5
